Senior Director of Commercial Strategy, COMPASS Pathways
$240-275k
+ discretionary bonus + equity
Biotech accelerating patient access to evidence-based innovation in mental health
Be an early applicant
Biotech accelerating patient access to evidence-based innovation in mental health
201-500 employees
Be an early applicant
$240-275k
+ discretionary bonus + equity
201-500 employees
Company mission
To accelerate patient access and experience to evidence-based innovation in mental health care, to achieve a vision of a world of mental wellbeing.
Role
Who you are
- Bachelor’s degree in Business, Life Sciences, Project Management, or a related field; advanced degree preferred
- Significant experience in pharmaceutical or biotech commercial launch, program management, or strategic operations roles, including experience leading complex, cross-functional initiatives
- Demonstrated success driving launch readiness or large-scale business-critical programs in regulated environments
- Strong project and program management capability, including experience with integrated planning, governance, risk management, and executive communication
- Able to influence across a matrixed organization and build alignment without direct authority
- Strong judgment, structured thinking, and the ability to translate ambiguity into clear plans, priorities, and actions
- Excellent communication and stakeholder management skills, with confidence engaging senior leaders and cross-functional teams
- Comfortable operating in a fast-moving, growth-stage environment with evolving priorities and high visibility
- Mission-aligned and motivated by the opportunity to help transform mental health care, while reflecting Compass values of Compassion, Boldness, Inclusion, and Rigour
What the job involves
- The Senior Director, Commercial Strategy leads integrated launch planning for COMP360 in TRD, coordinating cross-functional activities across Commercial and key partner functions to ensure launch readiness. This role drives governance, execution, and visibility across milestones, risks, and dependencies to support a compliant and effective launch. This role is also future-focused, identifying opportunities for additional indications, studies, and growth for COMP360 and the organization
- Act as a “Chief of Staff” for Commercial Strategy
- Own the integrated launch plan for COMP360 in TRD, including critical path milestones, interdependencies, deliverables, assumptions, and key decision points
- Lead cross-functional launch governance, establishing operating rhythms, meeting cadences, status reporting, and escalation pathways that support effective execution
- Partner across Sales, Marketing, Market Access, Medical Affairs, Regulatory, Quality, IT, Finance, and Supply Chain to ensure launch activities are aligned, sequenced, and progressing against plan
- Identify program risks, gaps, and bottlenecks early, and drive mitigation plans with appropriate owners to maintain readiness timelines
- Build and maintain launch readiness frameworks, dashboards, and trackers that provide clear visibility to leadership on progress, risks, and resource needs
- Coordinate the development of core launch enablers, including field readiness plans, systems readiness, process documentation, training coordination, and compliance-related activities
- Support executive-level decision making by synthesizing complex cross-functional inputs into concise recommendations, trade-offs, and action plans
- Ensure strong collaboration with commercial operations and technology partners to align systems, reporting, analytics, and tools required for launch execution
- Manage external vendors and launch-related partners where applicable, ensuring timely delivery, clear accountability, and effective issue resolution
- Contribute to post-launch planning, transition readiness, and lessons-learned processes to support sustainable execution beyond initial launch milestones
- Strategy as it relates to additional indications, P3B/4 studies, RWE, etc
- Future focused planning for future indications including PTSD
- Identify and explore other future opportunities for the company
Our take
There’s been a major movement towards treating mental health issues with psychedelics over the last few years. While the vast majority of this work is still in R&D and clinical trials, the space has become awash with capital investment, with a handful of companies even going public.
COMPASS Pathways is one of those to go public, along with MindMed in 2020. The company is developing methods for treating depression and other mental health issues with psilocybin – the naturally occurring psychedelic chemical found in mushrooms.
The growth of COMPASS from being founded in 2016 to its IPO in 2020 has been extraordinary. There have been a few ups and downs since then (as is the case with most PLCs), with each rise and fall dependent on the progress of its trials. However, the fact that the company appointed former Otsuka Pharmaceutical executive Kabir Nath as CEO in 2022, bolstered by $285 million in private placement VC, shows that it's determined to stay ahead of the competition.
Freddie
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 3 rounds)
Apr 2020
$80m
SERIES B
Oct 2018
$25m
SERIES A
Total funding: $109.1m
Company benefits
- Pension and retirement savings plans
- Flexible working arrangements, including flexible hours, working-from-home and hybrid working
- Community Circles: a regular opportunity for team members to connect, share lived experiences, inspire others, and learn from each other
- Regular virtual and in-person social events, including a London-based hiking group, art and creative workshops, food and drinks evenings, team picnics, and holiday celebrations
- Comprehensive and market-leading health and wellness benefits including company paid healthcare plans
- Confidential counselling or therapy sessions via our Employee Assistance Programme
- Support from our own dedicated Community Wellbeing Lead to guide team members to our resources
- Workplace wellbeing initiatives, including employee-led yoga, meditation, mindfulness, and support groups for parents and carers and for people who are neurodiverse
- Breast-feeding facilities at our London office
- Wellbeing Leadership Forums for Line Managers
- Generous paid time off/annual leave allowance including one company closing per year and your birthday off
- Generous paid parental leave for eligible team members, up to 39 weeks
- Paid family and dependent care leave in addition to parental leave
- Job architecture, providing employees with guidance and clear pathways for developing and progressing their career and twice-yearly promotions cycle
- A process for performance and development goals that is tied to employees receiving feedback throughout the year and assessing individual performance and rewards at the end of the year
- Dedicated internal resources including regular webinars to support employees’ personal development and career goals
- A learning curriculum of courses on offer delivered by external experts to develop specific skill areas
- Dedicated effort for early career team members to learn skills and strategies for advancement
Company HQ
Soho, London, UK
Leadership
Kabir Nath
(CEO)Joined as CEO in 2022, having served as Senior Managing Director of Global Pharmaceutical Business at Japanese company Otsuka. Prior to this, they spent a decade at Bristol Myers Squibb in a number of roles including SVP of Virology, US Pharmaceuticals.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 1 more job at COMPASS Pathways